AI assistant
Sending…
Sensei Biotherapeutics, Inc. — Director's Dealing 2021
Apr 5, 2021
35217_dirs_2021-04-05_adde7ff0-8023-442e-a242-3a629170c51e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Sensei Biotherapeutics, Inc. (SNSE)
CIK: 0001829802
Period of Report: 2021-04-01
Reporting Person: English Jessie (Director)
More from Sensei Biotherapeutics, Inc.
Proxy Solicitation & Information Statement
2026
May 22
Regulatory Filings
2026
May 22
Proxy Solicitation & Information Statement
2026
May 21
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 27
Regulatory Filings
2026
Apr 16